ICCA STROKE 2018 - How to treat stroke in the cathlab

  • Interactive case based discussions
  • Key note lectures from experts in the field
  • Simulator training
  • Latest clinical trials
  • Newest guidelines

Acute catheter-based stroke interventions have been proven to be superior to systemic lysis in a number of randomised trials. With a number needed to treat (NNT) of only 2, acute stroke interventions are extremely efficient. Up to 20% of acute strokes can and should be treated with catheter techniques, but there are not enough interventionists capable of performing these procedures outside of large stroke centers. We want to change this by educating interventionists from different specialities about catheter-based stroke interventions.

Please join us at ICCA STROKE, April 20 - 21, 2018 in Warsaw, Poland. Learn how to remove clots from the brain and make a real difference in the life of your patients. There is no other catheter intervention you can perform with such a huge impact!

ICCA Stroke is an interdisciplinary and interactive course with lectures from leading experts in the field, recorded cases, step by step presentations, debates and hands-on workshops. You will be guided through the different aspects of stroke treatment: patient selection, imaging, indication, how to do it, post-procedural care as well as avoiding and managing complications.

The meeting is designed for interventionists from all fields specializing in acute stroke intervention, vascular surgeons, neurologists and stroke physicians, anesthetists and anyone involved in endovascular stroke treatment, pre- and postprocedural care.

The ICCA Stroke meeting is facilitated by the World Federation for Interventional Stroke Treatments - WIST with the aim to ensure that acute catheter based stroke intervention procedures are only performed by well trained doctors. The meeting includes an examination and provides the foundation for further training lead by WIST in dedicated stroke centers.

With the meeting attracting around 300 attendees from around the world in 2017, we are confident that ICCA Stroke 2018 will be an even greater success.

We look forward to seeing you in Warsaw!

Iris Grunwald

On behalf of the board of directors


Iris Grunwald, MD, Anglia Ruskin University, Chelmsford, UK & Southend University Hospital,
Southend-on-Sea, UK

L. Nelson Hopkins, MD, University at Buffalo, Buffalo, USA

Klaus Mathias, MD, Asklepios Klinik St. Georg, Hamburg, Germany

Horst Sievert, MD, CardioVascular Center Frankfurt CVC, Frankfurt, Germany


Stefan Bertog, MD, CardioVascular Center Frankfurt CVC, Frankfurt, Germany & Minneapolis VA Medical Center, Minneapolis, USA

Adam Kobayashi, MD, Institute of Psychiatry and Neurology, Warsaw, Poland

Piotr Musialek, MD, John Paul II Hospital, Krakow, Poland

Piotr Odrowaz-Pieniazek, MD, Jagiellonian University, Krakow, Poland

Adnan Siddiqui, MD, University at Buffalo, Buffalo, USA

Kenneth Snyder, MD, University at Buffalo, Buffalo, USA

ICCA STROKE 2018 is supported by:

World Federation For Interventional Stroke Treatment